<?xml version="1.0" encoding="UTF-8"?>
<billStatus>
  <bill>
    <titles>
      <item>
        <chamberName />
        <titleType>(Extracted from GPO) Short Titles as Introduced</titleType>
        <title>Cannabidiol Research Expansion Act</title>
        <parentTitleType />
        <chamberCode />
      </item>
      <item>
        <chamberName />
        <titleType>Short Titles as Introduced</titleType>
        <title>Cannabidiol Research Expansion Act</title>
        <parentTitleType />
        <chamberCode />
      </item>
      <item>
        <chamberName />
        <titleType>Official Title as Introduced</titleType>
        <title>A bill to require the Attorney General to make a determination as to whether cannabidiol should be a controlled substance and listed in a schedule under the Controlled Substances Act and to expand research on the potential medical benefits of cannabidiol and other marihuana components.</title>
        <parentTitleType />
        <chamberCode />
      </item>
      <item>
        <chamberName />
        <titleType>Display Title</titleType>
        <title>Cannabidiol Research Expansion Act</title>
        <parentTitleType />
        <chamberCode />
      </item>
    </titles>
    <committeeReports />
    <sponsors>
      <item>
        <firstName>DIANNE</firstName>
        <identifiers>
          <lisID>1332</lisID>
          <gpoId>8338</gpoId>
          <bioguideId>F000062</bioguideId>
        </identifiers>
        <party>D</party>
        <bioguideId>F000062</bioguideId>
        <lastName>FEINSTEIN</lastName>
        <fullName>Sen. Feinstein, Dianne [D-CA]</fullName>
        <byRequestType />
        <middleName />
        <state>CA</state>
      </item>
    </sponsors>
    <title>Cannabidiol Research Expansion Act</title>
    <actions>
      <actionByCounts>
        <senate>2</senate>
      </actionByCounts>
      <actionTypeCounts>
        <referredToCommittee>1</referredToCommittee>
        <introducedInSenate>1</introducedInSenate>
      </actionTypeCounts>
      <item>
        <actionDate>2017-05-25</actionDate>
        <committee>
          <systemCode>ssju00</systemCode>
          <name>Judiciary Committee</name>
        </committee>
        <links>
          <link>
            <name>S3220-3221</name>
            <url>https://www.congress.gov/congressional-record/volume-163/senate-section/page/S3220-3221</url>
          </link>
        </links>
        <sourceSystem>
          <name>Senate</name>
          <code>0</code>
        </sourceSystem>
        <text>Read twice and referred to the Committee on the Judiciary. (Sponsor introductory remarks on measure: CR S3220-3221)</text>
        <type>IntroReferral</type>
      </item>
      <item>
        <sourceSystem>
          <name>Library of Congress</name>
          <code>9</code>
        </sourceSystem>
        <actionDate>2017-05-25</actionDate>
        <text>Introduced in Senate</text>
        <type>IntroReferral</type>
        <links />
        <committee />
        <actionCode>10000</actionCode>
      </item>
    </actions>
    <summaries>
      <billSummaries>
        <item>
          <lastSummaryUpdateDate>2018-01-30T20:38:10Z</lastSummaryUpdateDate>
          <updateDate>2017-05-25T04:00:00Z</updateDate>
          <versionCode>00</versionCode>
          <text><![CDATA[<p><b>Cannabidiol Research Expansion Act</b></p> <p>This bill requires the Drug Enforcement Administration (DEA) and the Department of Health and Human Services to each evaluate whether cannabidiol, the nonpsychoactive substance derived from marijuana or the synthetic formulation, should be a controlled substance under the Controlled Substances Act. After taking into consideration the evaluations, the DEA must initiate proceedings for classifying cannabidiol as a controlled substance if control is warranted.</p> <p>The bill expands the authority for: (1) conducting medical research on cannabidiol and other nonpsychoactive components of marijuana, and (2) possessing or transporting cannabidiol or any other nonpsychoactive component of marijuana for certain medicinal purposes.</p> <p>The Department of Justice shall register an applicant to manufacture or distribute cannabidiol or marijuana for the purpose of commercial production if approved by HHS. </p> <p>Physicians who are licensed under state law may discuss the potential harms and benefits of cannabidiol or those components of marijuana as a treatment with their patients or the legal guardians of underage patients.</p> <p>The bill terminates four years after enactment.</p>]]></text>
          <name>Introduced in Senate</name>
          <actionDesc>Introduced in Senate</actionDesc>
          <actionDate>2017-05-25</actionDate>
        </item>
      </billSummaries>
    </summaries>
    <recordedVotes />
    <billNumber>1276</billNumber>
    <calendarNumbers />
    <cosponsors>
      <item>
        <lastName>GRASSLEY</lastName>
        <sponsorshipDate>2017-05-25</sponsorshipDate>
        <party>R</party>
        <state>IA</state>
        <bioguideId>G000386</bioguideId>
        <middleName>ERNEST</middleName>
        <sponsorshipWithdrawnDate />
        <fullName>Sen. Grassley, Chuck [R-IA]</fullName>
        <firstName>CHARLES</firstName>
        <isOriginalCosponsor>True</isOriginalCosponsor>
        <identifiers>
          <gpoId>8316</gpoId>
          <bioguideId>G000386</bioguideId>
          <lisID>457</lisID>
        </identifiers>
      </item>
      <item>
        <lastName>DURBIN</lastName>
        <sponsorshipDate>2017-05-25</sponsorshipDate>
        <party>D</party>
        <state>IL</state>
        <bioguideId>D000563</bioguideId>
        <middleName>J.</middleName>
        <sponsorshipWithdrawnDate />
        <fullName>Sen. Durbin, Richard J. [D-IL]</fullName>
        <firstName>RICHARD</firstName>
        <isOriginalCosponsor>True</isOriginalCosponsor>
        <identifiers>
          <lisID>326</lisID>
          <gpoId>8326</gpoId>
          <bioguideId>D000563</bioguideId>
        </identifiers>
      </item>
      <item>
        <lastName>Tillis</lastName>
        <sponsorshipDate>2017-05-25</sponsorshipDate>
        <party>R</party>
        <state>NC</state>
        <bioguideId>T000476</bioguideId>
        <middleName>Roland</middleName>
        <sponsorshipWithdrawnDate />
        <fullName>Sen. Tillis, Thom [R-NC]</fullName>
        <firstName>Thomas</firstName>
        <isOriginalCosponsor>True</isOriginalCosponsor>
        <identifiers>
          <bioguideId>T000476</bioguideId>
          <lisID>2291</lisID>
          <gpoId />
        </identifiers>
      </item>
      <item>
        <lastName>Ernst</lastName>
        <sponsorshipDate>2017-05-25</sponsorshipDate>
        <party>R</party>
        <state>IA</state>
        <bioguideId>E000295</bioguideId>
        <middleName />
        <sponsorshipWithdrawnDate />
        <fullName>Sen. Ernst, Joni  [R-IA]</fullName>
        <firstName>Joni</firstName>
        <isOriginalCosponsor>True</isOriginalCosponsor>
        <identifiers>
          <lisID>2283</lisID>
          <bioguideId>E000295</bioguideId>
          <gpoId />
        </identifiers>
      </item>
      <item>
        <lastName>Whitehouse</lastName>
        <sponsorshipDate>2017-07-11</sponsorshipDate>
        <party>D</party>
        <state>RI</state>
        <bioguideId>W000802</bioguideId>
        <middleName />
        <sponsorshipWithdrawnDate />
        <fullName>Sen. Whitehouse, Sheldon [D-RI]</fullName>
        <firstName>Sheldon</firstName>
        <isOriginalCosponsor>False</isOriginalCosponsor>
        <identifiers>
          <gpoId>8264</gpoId>
          <lisID>1823</lisID>
          <bioguideId>W000802</bioguideId>
        </identifiers>
      </item>
      <item>
        <lastName>Kaine</lastName>
        <sponsorshipDate>2017-11-08</sponsorshipDate>
        <party>D</party>
        <state>VA</state>
        <bioguideId>K000384</bioguideId>
        <middleName />
        <sponsorshipWithdrawnDate />
        <fullName>Sen. Kaine, Tim [D-VA]</fullName>
        <firstName>Timothy</firstName>
        <isOriginalCosponsor>False</isOriginalCosponsor>
        <identifiers>
          <gpoId />
          <lisID>2176</lisID>
          <bioguideId>K000384</bioguideId>
        </identifiers>
      </item>
    </cosponsors>
    <version>1.0.0</version>
    <subjects>
      <billSubjects>
        <policyArea>
          <name>Crime and Law Enforcement</name>
        </policyArea>
        <legislativeSubjects>
          <item>
            <name>Alternative treatments</name>
          </item>
          <item>
            <name>Child health</name>
          </item>
          <item>
            <name>Drug therapy</name>
          </item>
          <item>
            <name>Drug trafficking and controlled substances</name>
          </item>
          <item>
            <name>Education programs funding</name>
          </item>
          <item>
            <name>Government studies and investigations</name>
          </item>
          <item>
            <name>Health personnel</name>
          </item>
          <item>
            <name>Health programs administration and funding</name>
          </item>
          <item>
            <name>Higher education</name>
          </item>
          <item>
            <name>Licensing and registrations</name>
          </item>
          <item>
            <name>Medical education</name>
          </item>
          <item>
            <name>Medical research</name>
          </item>
          <item>
            <name>Neurological disorders</name>
          </item>
          <item>
            <name>Research administration and funding</name>
          </item>
          <item>
            <name>Trade restrictions</name>
          </item>
        </legislativeSubjects>
      </billSubjects>
    </subjects>
    <latestAction>
      <text>Read twice and referred to the Committee on the Judiciary. (Sponsor introductory remarks on measure: CR S3220-3221)</text>
      <links />
      <actionDate>2017-05-25</actionDate>
    </latestAction>
    <originChamber>Senate</originChamber>
    <laws />
    <notes />
    <createDate>2017-05-26T00:41:40Z</createDate>
    <billType>S</billType>
    <updateDate>2018-02-06T16:45:29Z</updateDate>
    <policyArea>
      <name>Crime and Law Enforcement</name>
    </policyArea>
    <cboCostEstimates />
    <introducedDate>2017-05-25</introducedDate>
    <amendments />
    <relatedBills />
    <congress>115</congress>
    <committees>
      <billCommittees>
        <item>
          <subcommittees />
          <type>Standing</type>
          <systemCode>ssju00</systemCode>
          <activities>
            <item>
              <name>Referred to</name>
              <date>2017-05-25T20:17:07Z</date>
            </item>
          </activities>
          <name>Judiciary Committee</name>
          <chamber>Senate</chamber>
        </item>
      </billCommittees>
    </committees>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>

